Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studies

American Journal of Cardiovascular Drugs

Volumn 14, Issue 5, 2014, Pages 357-366

  Dalbeni, Andrea ^a   Delva, Pietro ^a   Minuz, Pietro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYTOKINE; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN;

BLOOD PRESSURE; CALCIUM TRANSPORT; DRUG EFFECT; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; INTERVENTION STUDY; METABOLITE; NONHUMAN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANIMAL; COMPLICATION; DIET SUPPLEMENTATION; EARLY INTERVENTION; PATHOLOGY;

ANIMALS; DIETARY SUPPLEMENTS; EARLY MEDICAL INTERVENTION; HEART FAILURE; HUMANS; INTERVENTION STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84907593777     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.1007/s40256-014-0080-5     Document Type: Review

References (54)

1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137-46.
2. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138(1):24-32.
3. Sundquist J, Winkleby MA, Pudraric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109-16.
4. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949-56.
5. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91-100.
6. Walles CC, Whooley MA, Karumanchi SA, Hod T, ThadhaniR, Berg AH, Ix JH, Mukamal KJ. Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the heart and soul study. Am J Epidemiol. 2014;179(11):1279-87.
7. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-37.
8. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
9. van der Wielen RP, Löwik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346(8969):207-10.
10. Ky B, Shults J, Keane MG, Sutton MS, Wolf M, Feldman HI, Reese PP, Anderson CA, Townsend RR, Deo R, Lo J, Gadegbeku C, Carlow D, Sulik MJ, Leonard MB. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail. 2013;6(4):817-24. doi: 10.1161/CIRCHEARTFAILURE.112.000105. Epub 2013 Jun 7.
11. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocytes contractility. Endocrinology. 2008;149(2):558-64.
12. O'Connell TD, Simpson RU. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int. 1996;20(9):621-4.
13. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103(3-5):416-9.
14. Gupta GK, Agrawal T, DelCore M, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 2012;93(1):82-90.
15. Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 2011;378:704-12.
16. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010;362:228-38.
17. O'Connell TD, Simpson RU. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int. 1996;20:621-4.
18. Chen S, Glenn DJ, Ni W, Grigsby C, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension. 2008;52:1106-12.
19. Resnick LM, Muller FB, Laragh JH. Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;110:649-54.
20. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.
21. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063-9.
22. van Ballegooijen AJ, Kestenbaum B, Sachs MC, de Boer IH, Siscovick DS, Hoofnagle An, Ix KJH, Visser M, Brouwer IA. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: the multi ethnic study of atherosclerosis. JACC. 2014;63(12):1214-22.
23. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352:709-10.
24. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effect of a short-term vitamin D (3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86:1633-7.
25. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, Baresford SAA, Connelly SA, Curb JD, Grimm RH, Kotchen TA, Kuller LH, Wasswertheil-Smoller S, Thomson CA, Torner JC, For the Women's Health Initiative Investigators. Effect of calcium and vitamin D supplementation on blood pressure: the women's health initiative randomized trial. Hypertension. 2008;52(5):847-55.
26. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25(11):1215-22.
27. Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, McMurdo ME. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med. 2013;173(18):1672-9.
28. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754-9.
29. Rauchhaus M, Doehner W, Francis DP. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060-7.
30. Devries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995;27:537-41.
31. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1 alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005;35:217-24.
32. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927-35.
33. 2+uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem. 1987;262(6):2536-41.
34. Selles J, Massheimer V, Santillan G, Marinissen MJ, Boland R. Effects of calcitriol and its analogues, calcipotriol (MC 903) and 20-epi-1alpha, 25-dihydroxyvitamin D3 (MC 1288), on calcium influx and DNA synthesis in cultured muscle cells. Biochem Pharmacol. 1997;53(12):1807-14.
35. Santillán GE, Vazquez G, Boland RL. Activation of a beta-adrenergic-sensitive signal transduction pathway by the secosteroid hormone 1,25-(OH) 2-vitamin D3 in chick heart. J Mol Cell Cardiol. 1999;31(5):1095-104.
36. Stefanelli T, Abela C, Frank H. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab. 1997;82:106-12.
37. van Ballegooijen AJ, Visser M, Cotch MF, Arai AE, Garcia M, Harris TB, Launer LJ, Eirìksdòttir G, Gudnason V, Brouwer IA. Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik. J Clin Endocrinol Metab. 2013;98(6):2544-52.
38. WHO scientific Group on the Prevention and management of osteoporosis: report of a WHO scientific group. Geneva: World Health Organization, 2003. World Health Organ Tech Rep Ser. 2003;921:1-164.
39. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin proc. 2011;86(1):50-60.
40. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97(4):1146-52.
41. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33(1):73-81.
42. Lemmillä S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol. 1998;18(5):404-10.
43. Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr. 2012;22(2):284-91.
44. Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, Cleland JG. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005;26(21):2238-44.
45. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010;3(2):195-201.
46. Boxer RS, Kenny Am, Schmotzer BJ, Vest M, Fiutem JJ, Pina IL. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart failure. 2013;1(1):84-90.
47. Boxer RS, Hoit BD, Schmotzer BJ, Stefano GT, Gomes A, Negrea L. The effect of vitamin D on aldosterone and health status I patients with heart failure. J Card Fail. 2014;20(5):334-42.
48. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846-54. Erratum in: Circulation. 2007;115(19).
49. Zia AA, Komolafe BO, Moten M, Ahokas RA, McGee JE, William Rosenberg E, Bhattacharya SK, Weber KT. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci. 2011;341(2):113-8.
50. Schierbeck LL, Rejnmark L, Tofteng C, Stilgren L, Eiken P, Mosekilde L, Køber L, Jensen JE. Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events - a 16-year follow-up study. Eur J Endocrinol. 2012;167(4):553-60.
51. Shedeed SA. Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol. 2011. doi: 10.1007/s00246-012-0199-6.
52. Schroten N, Ruifrok WPT, Kleijen L, Cokter MM, Sillje HH, Heerspink HJL, Bakker SJL, Kema IP, van Gilst WH, van Veldhuisen DJ, Hillege HL, de Boer RA. Short term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166:357-64.
53. Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P. Effect of six months vitamin D supplementation in patients with heart failure: a randomized double blind controlled trial. Nutr Metab Card Dis 2014. pii: S0939-4753(14):00086-6. doi: 10.1016/j.numecd.2014.02.015.
54. Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J card. 2013;169:106-11.